Video

Looking at the Future of Hospital Safety and Treatment Resistance

Author(s):

The search for newer antimicrobial agents is a focus of those looking to help prevent patients from developing potentially dangerous conditions while admitted to the hospital.

The search for newer antimicrobial agents is a focus of those looking to help prevent patients from developing potentially dangerous conditions while admitted to the hospital.

As of now the US Food and Drug Administration has approved two such agents, but Thomas M. File, Jr., from Summa Health System said he hopes to see that number grow in the near future in order to better treat more potential at risk patients. File said they are also working to ensure that the organisms will not cause as much damage to the host systems makgin them less of an overall health threat to the patients.

Related Videos
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
© 2024 MJH Life Sciences

All rights reserved.